; and (3) by moving the left margin 2 ems to the left. (c) Effective date The amendments made by this section shall take effect on the date that is 1 year after the date of enactment of this Act. 202. Improving reporting requirements and developing standards for the use of drug use review boards in State Medicaid programs (a) In general Section 1927(g)(3) of the Social Security Act ( 42 U.S.C. 1396r–8(g)(3) ) is amended— (1) by amending subparagraph (B) to read as follows: (B) Membership (i) In general The membership of the DUR Board shall include health care professionals who have recognized knowledge and expertise in one or more of the following: (I) The clinically appropriate prescribing of covered outpatient drugs. (II) The clinically appropriate dispensing and monitoring of covered outpatient drugs. (III) Drug use review, evaluation, and intervention. (IV) Medical quality assurance. (ii) Membership requirements The membership of the DUR Board shall— (I) be made up of at least 1/3 but no more than 51 percent members who are licensed and actively practicing physicians and at least 1/3 members who are licensed and actively practicing pharmacists; and (II) include at least 1 licensed and actively practicing physician and at least 1 licensed and actively practicing pharmacist, each of whom— (aa) is independent and free of any conflict, including with respect to manufacturers, medicaid managed care entities, or pharmacy benefit managers; and (bb) has expertise in the care of 1 or more categories of individuals who are likely to be eligible for benefits under this title, including elderly or disabled individuals, children with complex medical needs, or low-income individuals with chronic illnesses; and (III) be made publicly available. (iii) Conflict of interest policy The State shall establish and implement a conflict of interest policy for the DUR Board that— (I) is publicly accessible